Vaccines· 2026Q1
Cellular and Humoral Immune Responses in Anti-N Seropositive and Seronegative Vaccinated Participants: Insights from the Bialystok PLUS Study
- 0citations
- Q1SCImago
- 2026year
Short summary
Vaccinated individuals with prior SARS-CoV-2 infection (anti-N seropositive) showed a 3.57-fold higher cellular immune response compared to those without prior infection (anti-N seronegative).
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Infectious Diseases
Infectious DiseasesMedicine